CN103020778A - Standardized therapy management system used for hematological malignancy patients - Google Patents

Standardized therapy management system used for hematological malignancy patients Download PDF

Info

Publication number
CN103020778A
CN103020778A CN 201210561454 CN201210561454A CN103020778A CN 103020778 A CN103020778 A CN 103020778A CN 201210561454 CN201210561454 CN 201210561454 CN 201210561454 A CN201210561454 A CN 201210561454A CN 103020778 A CN103020778 A CN 103020778A
Authority
CN
Grant status
Application
Patent type
Prior art keywords
information
module
patients
management
treatment
Prior art date
Application number
CN 201210561454
Other languages
Chinese (zh)
Inventor
高蕾
张曦
李云龙
Original Assignee
中国人民解放军第三军医大学第二附属医院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Abstract

A standardized therapy management system used for hematological malignancy patients comprises a data base, a recording module, an evaluation module and a statistics module. The standardized therapy management system used for hematological malignancy patients comprehensively records disease information of the patients; provides standardized therapy, evaluation procedure and examination and testing methods; and manages therapeutic evaluation time and reexamination time nodes of the patients in standardized mode. Doctors can improve the capability of clinician standardized therapy management through the statistics module, work omissions caused by inadequate experience and negligence can be reduced, and state, curative effect and prognoses of the hematological malignancy patients can be evaluated through the evaluation module.

Description

用于恶性血液病患者的规范化治疗管理系统 Standardized management system for the treatment of patients with hematologic malignancies

技术领域 FIELD

[0001] 本发明涉及医疗领域,特别是一种疾病治疗管理系统。 [0001] The present invention relates to the medical field, particularly in the treatment of a disease management.

背景技术 Background technique

[0002] 恶性血液病,包括白血病、淋巴瘤、骨髓瘤等,具有治疗周期长、治疗方案复杂、疗效评估标准繁多等特点。 [0002] hematological malignancies, including leukemia, lymphoma, myeloma and the like, having a treatment cycle is long, complex therapeutic regimen, many characteristics of efficacy evaluation criteria. 一方面由于疾病本身的特点,需要患者长期、反复返院治疗,另一方面,由于对疾病认识的深入,需要对既往的治疗效果有一种合理判定。 On the one hand due to the nature of the disease itself, patients need long-term, repeated back to hospital for treatment, on the other hand, due to the in-depth understanding of disease, the need for a rational judgment on the therapeutic effect of past. 而目前恶性血液病治疗和疗效的医学评估,主要依赖于医生自己经验的总结,大多数临床医生置身于繁忙的医疗工作,对入院治疗的恶性血液病患者缺乏全面系统的总结和评价,另外受知识更新速度快慢的影响,一些治疗方法和预后评价标准明显落后于国际治疗和评价进展,导致患者无效评价和过度治疗等。 The medical evaluation of the efficacy of current treatment of hematologic malignancies and, mainly depends on the doctor summed up his experience, most clinicians being in a busy medical practice, the lack of comprehensive and systematic summary and evaluation of hospitalized patients with hematologic malignancies, and the other by the speed of updating knowledge of the impact of some of the treatment and prognosis evaluation criteria significantly behind international treatment and evaluation of progress, leading to excessive invalid patient evaluation and treatment.

[0003] 传统的患者疾病治疗管理,主要依靠患者首次入院后医生简单的纸质版病历总结,其不足在于:1.缺乏系统性和连贯性:患者治疗方案的制定主要立足于本次入院时的疾病状态,对患者疾病演进认识不够,如患者治疗过程中更换医生或医院,治疗和随访的延续性更无法保证;2.不同病种风险和疗效评价体系差异性明显:需医生详细了解每一种疾病评价体系的详细内容,任务繁重;3.对评价时间节点和疗效标准可能因理解力的不同而出现参差不齐;4.随访事项和返院治疗时间需规范化管理,避免部分患者时间观念不强和对疾病重视程度不够,而导致严重并发症和疾病复发情况的发生;5.无法实现临床有效数据的调阅和统计:临床病历中患者治疗相关信息因不同医生的记录习惯而不同,部分病例中会出现疾病评估关键信息的缺失,目前临床适行的电 When a patient treatment plan is mainly based on this admission: [0003] Traditional treatment of patients with disease management, mainly rely on patients for the first time admitted to hospital after a doctor simple paper-based medical record summary version, which is less than that: a lack of systematic and coherence. disease status, not enough understanding of the evolution of patients with the disease, such as replacement therapy in patients with a doctor or hospital, treatment and follow-up can not guarantee more continuity; 2 different evaluation system differences disease risks and benefits clear: to be a doctor to learn more about each Details of the evaluation system of a disease, a heavy task; 3 may vary depending on uneven understanding of the emergence of the evaluation time node and efficacy standards; 4. matters and follow-up treatment time required to return to hospital standardized management, some patients avoid time concept is not strong enough and the importance of the disease, which led to serious complications and recurrence of the disease; 5 can not achieve statistical and clinically effective access to data: clinical history of patient treatment information due to different doctors and different habits of record , in some cases there will be missing critical information to assess disease, current clinical suitable electrical lines 病历系统尚不能有效调阅恶性血液病诊断、治疗和随访评估的有效数据。 Effective access to medical records system is not yet valid data hematologic malignancies diagnosis, treatment and follow-up assessment.

发明内容 SUMMARY

[0004] 本发明的目的就是提供一种用于恶性血液病患者的规范化治疗管理系统,它便于全面记录患者信息,提供标准化治疗、评价流程和检查、检验方法,提高临床医生规范化治疗管理的能力,利于对恶性血液病患者病情、疗效和预后的评估。 Capacity [0004] The object of the present invention is to provide a standardized treatment of patients with hematologic malignancies management system for a patient which facilitates comprehensive record information, provides a standardized treatment, inspection and evaluation procedure, test methods, the clinician to improve the management of standardized treatment , which will help, and to assess the efficacy of the disease in patients with hematologic malignancies prognosis.

[0005] 本发明的目的是通过这样的技术方案实现的,它包括有数据库,所述系统还包括有记录模块、评估模块和统计模块; [0005] The object of the present invention is achieved by a technical solution, which comprises a database, the system further comprises a recording module, an evaluation module and a statistics module;

记录模块,用于输入患者信息,并存储在数据库内;患者信息包括有患者的发病经过、典型症状、体征、检查检验、多次治疗用药方案、不良反应、并发症、典型图像采集、疗效和复诊日期;患者信息还包括有造血干细胞移植患者的HLA配型结果、预处理方案、不良反应、并发症、典型图像采集、移植物抗宿主病、肝静脉闭塞病治疗、免疫抑制方案、疗程和微小残留病检测信息; A recording module for inputting patient information, and stored in a database; patient information includes a patient after onset, the typical symptoms, signs and laboratory are, repeated treatment regimen, adverse reactions and complications typical image acquisition, efficacy and referral date; patient information further comprises results of the HLA typing of hematopoietic stem cell transplant patients, conditioning regimen, adverse reactions and complications typical image acquisition, graft versus host disease, hepatic veno-occlusive disease therapy, immunosuppressive protocols, treatment, and MRD detection information;

评估模块,按照恶性血液病最新国际诊断、分期、危险度和疗效评估标准,根据记录模块录入的信息进行数据评估,并存储在数据库内; Evaluation module, according to the latest international diagnosis of hematological malignancies, staging, risk assessments, and efficacy criteria, evaluate the data entry module in accordance with recording information, and stored in a database;

统计模块,对记录模块录入的信息和评估模块评估的信息进行统计,包括患者基本信息、实验室检查结果、诊断信息、治疗方案和疗效信息,生成相应报表,并存储在数据库内。 Statistics module, information recording module and evaluation module entry information for statistical assessment, including basic patient information, lab test results, diagnostic information, treatment options and efficacy information, generate reports, and stored in the database.

[0006] 进一步,所述记录模块录入的信息由医生手动录入。 [0006] Further, the recording information is entered manually by the doctor module entry.

[0007] 进一步,所述系统还包括有用户管理模块,用于管理所有用户信息,用户信息包括有临床医生及病人的信息。 [0007] Further, the system further comprises a user management module for managing all user information, including user information and patient information clinicians.

[0008] 进一步,所述系统还包括有系统管理模块,用于权限管理、各模块内容调用及修改管理和通知时间管理,通知时间管理是指针对不同恶性血液病的疾病特点和治疗方式,在需要治疗、随访的时候通知患者治疗和复查。 [0008] Further, the system further comprises a system management module for rights management, call and modify the contents of each module management and notification time management, time management is notified and disease characteristics for different treatment of hematologic malignancies, in in need of treatment, patients were followed up when the notification and review.

[0009] 由于采用了上述技术方案,本发明具有如下的优点: [0009] By adopting the technical solution of the present invention has the following advantages:

本发明通过记录模块全面记录患者的病症信息,提供标准化治疗、评价流程和检查、检验方法,规范化管理患者疗效评价时间和复查时间节点,医生通过统计模块可以提高临床医生规范化治疗管理的能力,减少因经验不足和疏忽造成的工作疏漏,通过评估模块对恶性血液病患者病情、疗效和预后进行评估。 The present invention fully recorded by the recording module disease patient information, standardized treatment, evaluation processes and inspection, testing methods, standardized management of patient outcome evaluation time and review time nodes, doctors can improve the ability of clinicians standardized treatment management by statistics module, reducing due to lack of experience and inadvertent omission of work, to assess the disease, the efficacy and the prognosis of patients with hematologic malignancies by evaluation module.

[0010] 本发明的其他优点、目标和特征在某种程度上将在随后的说明书中进行阐述,并且在某种程度上,基于对下文的考察研究对本领域技术人员而言将是显而易见的,或者可以从本发明的实践中得到教导。 [0010] Additional advantages, objects and features of the present invention will be to some extent set forth in the description which follows and, in part, based on a study of the following investigation to those skilled in the art will be apparent, or it may be learned from practice of the invention. 本发明的目标和其他优点可以通过下面的说明书和权利要求书来实现和获得。 Other objects and advantages of the invention may be realized and obtained by the following description and the appended claims.

附图说明 BRIEF DESCRIPTION

[0011] 本发明的附图说明如下。 [0011] The drawings of the present invention is described below.

[0012] 图1为本发明的结构示意图。 [0012] FIG. 1 is a schematic structural diagram of the present invention.

具体实施方式 detailed description

[0013] 下面结合附图和实施例对本发明作进一步说明。 Drawings and embodiments of the present invention will be further described [0013] below in conjunction.

[0014] 用于恶性血液病患者的规范化治疗管理系统,包括有数据库,其特征在于:所述系统还包括有记录模块、评估模块和统计模块; Treatment standardized management system [0014] for patients with hematologic malignancies, including a database, wherein: said system further comprises a recording module, an evaluation module and a statistics module;

记录模块,用于输入患者信息,并存储在数据库内;患者信息包括有患者的发病经过、典型症状、体征、检查检验、多次治疗用药方案、不良反应、并发症、典型图像采集、疗效和复诊日期;患者信息还包括有造血干细胞移植患者的HLA配型结果、预处理方案、不良反应、并发症、典型图像采集、移植物抗宿主病、肝静脉闭塞病治疗、免疫抑制方案、疗程和微小残留病检测信息; A recording module for inputting patient information, and stored in a database; patient information includes a patient after onset, the typical symptoms, signs and laboratory are, repeated treatment regimen, adverse reactions and complications typical image acquisition, efficacy and referral date; patient information further comprises results of the HLA typing of hematopoietic stem cell transplant patients, conditioning regimen, adverse reactions and complications typical image acquisition, graft versus host disease, hepatic veno-occlusive disease therapy, immunosuppressive protocols, treatment, and MRD detection information;

评估模块,按照恶性血液病最新国际诊断、分期、危险度和疗效评估标准,根据记录模块录入的信息进行数据评估,并存储在数据库内; Evaluation module, according to the latest international diagnosis of hematological malignancies, staging, risk assessments, and efficacy criteria, evaluate the data entry module in accordance with recording information, and stored in a database;

统计模块,对记录模块录入的信息和评估模块评估的信息进行统计,包括患者基本信息、实验室检查结果、诊断信息、治疗方案和疗效信息,生成相应报表,并存储在数据库内。 Statistics module, information recording module and evaluation module entry information for statistical assessment, including basic patient information, lab test results, diagnostic information, treatment options and efficacy information, generate reports, and stored in the database.

[0015] 记录模块录入的信息由医生手动录入。 Information [0015] recording module entered manually entered by the doctor.

[0016] 系统还包括有用户管理模块,用于管理所有用户信息,用户信息包括有临床医生及病人的信息。 [0016] The system further comprises a user management module for managing all user information, including user information and patient information clinicians.

[0017] 系统还包括有系统管理模块,用于权限管理、各模块内容调用及修改管理和通知时间管理,通知时间管理是指针对不同恶性血液病的疾病特点和治疗方式,在需要治疗、随访的时候通知患者治疗和复查。 [0017] The system also includes system management module for rights management, content modules and change management and notification call time management, time management is to inform and disease characteristics for different treatment of hematologic malignancies, in need of treatment, follow-up inform the patient when treatment and review.

[0018] 本发明在系统管理中配置好相应的权限模块信息,在用户管理中加入临床医生的数据以后,临床医生可以通过记录模块填写相关病情信息,包括有病患的临床表现、诊断、实验室检查、治疗情况、治疗效果、不良反应、监测点、监测指标和随访资料等。 [0018] The present invention is configured in the system management module authority information corresponding well, after addition of the clinician in the user management data, the clinician can fill in information recording module-related disease, including patients clinical presentation, diagnosis, experimental laboratory examination, treatment, treatment, adverse reactions, monitoring points, monitoring indicators and follow-up information. 所填写的信息完整的包括了病情诊断、治疗、监控和评估所需要的信息,然后医生通过详细的信息分析进行合理判断,提高程序化管理的能力,减少因经验不足和疏忽造成的工作疏漏,利于对恶性血液病患者病情和疗效的评估,合理利用医疗资源,减少个人和社会的卫生经济负担。 Fill in the complete information, including information on disease diagnosis, treatment, monitoring and evaluation of needed, then the doctor detailed information analysis of sound judgment, improve the ability to program management, reduce defective work caused by inexperience and negligence, conducive to the assessment of efficacy in patients with hematological malignancies and disease, the rational use of medical resources, reduce the economic burden on individuals and society health.

[0019] 最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本技术方案的宗旨和范围,其均应涵盖在本发明的权利要求范围当中。 [0019] Finally is noted that, the above embodiments are intended to illustrate and not limit the present invention, although the present invention has been described in detail with reference to preferred embodiments, those of ordinary skill in the art should be understood that the present invention technical solution modifications or equivalent replacements without departing from the spirit and scope of the present technical solution, which should be covered by the present invention which is claimed in the required range.

Claims (4)

  1. 1.用于恶性血液病患者的规范化治疗管理系统,包括有数据库,其特征在于:所述系统还包括有记录模块、评估模块和统计模块; 记录模块,用于输入患者信息,并存储在数据库内;患者信息包括有患者的发病经过、典型症状、体征、检查检验、多次治疗用药方案、不良反应、并发症、典型图像采集、疗效和复诊日期;患者信息还包括有造血干细胞移植患者的HLA配型结果、预处理方案、不良反应、并发症、典型图像采集、移植物抗宿主病、肝静脉闭塞病治疗、免疫抑制方案、疗程和微小残留病检测信息; 评估模块,按照恶性血液病最新国际诊断、分期、危险度和疗效评估标准,根据记录模块录入的信息进行数据评估,并存储在数据库内; 统计模块,对记录模块录入的信息和评估模块评估的信息进行统计,包括患者基本信息、实验室检查结果、诊 1. The standard treatment for patients with hematologic malignancies in the management system, including a database, wherein: said system further comprises a recording module, an evaluation module and a statistics module; recording module for inputting patient information, and stored in the database the; patient information includes a patient after onset, the typical symptoms, signs and laboratory are, repeated treatment regimen, adverse reactions and complications typical image acquisition, efficacy and referral date; patient information further comprises a hematopoietic stem cell transplant patients HLA typing result, conditioning regimen, adverse reactions and complications typical image acquisition, graft versus host disease, hepatic veno-occlusive disease therapy, immunosuppression, medications, and the minute residual disease detection information; evaluation module, in accordance with hematologic malignancies the latest international diagnosis, staging, risk and efficacy assessment criteria, data evaluation according to the information recording module entered and stored in the database; information statistics module, recording module input information and evaluation module evaluation statistics, including the patient's basic information, laboratory results, diagnostic 信息、治疗方案和疗效信息,生成相应报表,并存储在数据库内。 Information, the treatment regimen and efficacy information, generate reports, and stored in a database.
  2. 2.如权利要求1所述的用于恶性血液病患者的规范化治疗管理系统,其特征在于:所述记录模块录入的信息由医生手动录入。 2. The standard treatment for patients with hematologic malignancies management system according to claim 1, wherein: said recording module information entered by the physician manually entered.
  3. 3.如权利要求1所述的用于恶性血液病患者的规范化治疗管理系统,其特征在于:所述系统还包括有用户管理模块,用于管理所有用户信息,用户信息包括有临床医生及病人的信息。 3. The standard treatment for patients with hematologic malignancies management system according to claim 1, wherein: said system further comprises a user management module for managing all user information, the user information including clinicians and patients Information.
  4. 4.如权利要求1所述的用于恶性血液病患者的规范化治疗管理系统,其特征在于:所述系统还包括有系统管理模块,用于权限管理、各模块内容调用及修改管理和通知时间管理,通知时间管理是指针对不同恶性血液病的疾病特点和治疗方式,在需要治疗、随访的时候通知患者治疗和复查。 4. The standard treatment for patients with hematologic malignancies management system according to claim 1, wherein: said system further comprises a system management module for rights management, call and modify the contents of the modules and the notification time management management, notification management is time for a different disease characteristics and treatment of hematologic malignancies, in need of treatment, patients were followed up when the notification and review.
CN 201210561454 2012-12-21 2012-12-21 Standardized therapy management system used for hematological malignancy patients CN103020778A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210561454 CN103020778A (en) 2012-12-21 2012-12-21 Standardized therapy management system used for hematological malignancy patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210561454 CN103020778A (en) 2012-12-21 2012-12-21 Standardized therapy management system used for hematological malignancy patients

Publications (1)

Publication Number Publication Date
CN103020778A true true CN103020778A (en) 2013-04-03

Family

ID=47969360

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210561454 CN103020778A (en) 2012-12-21 2012-12-21 Standardized therapy management system used for hematological malignancy patients

Country Status (1)

Country Link
CN (1) CN103020778A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105956378A (en) * 2016-04-26 2016-09-21 成都聚恒康科技有限公司 Clinical decision supporting system of tumor diagnosis and treatment

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080045811A1 (en) * 1997-03-13 2008-02-21 Clinical Decision Support, Llc Disease management system and method including significant symptom filtering
CN102567646A (en) * 2012-01-16 2012-07-11 中国人民解放军第三军医大学第二附属医院 Self-management system used for patient with chronic airway disease
CN202331458U (en) * 2011-06-03 2012-07-11 首都医科大学附属北京朝阳医院 National malignant tumor interventional treatment registration system
CN102737165A (en) * 2012-06-07 2012-10-17 北京太元通软件科技有限公司 Clinical medication decision support system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080045811A1 (en) * 1997-03-13 2008-02-21 Clinical Decision Support, Llc Disease management system and method including significant symptom filtering
CN202331458U (en) * 2011-06-03 2012-07-11 首都医科大学附属北京朝阳医院 National malignant tumor interventional treatment registration system
CN102567646A (en) * 2012-01-16 2012-07-11 中国人民解放军第三军医大学第二附属医院 Self-management system used for patient with chronic airway disease
CN102737165A (en) * 2012-06-07 2012-10-17 北京太元通软件科技有限公司 Clinical medication decision support system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105956378A (en) * 2016-04-26 2016-09-21 成都聚恒康科技有限公司 Clinical decision supporting system of tumor diagnosis and treatment

Similar Documents

Publication Publication Date Title
Moody et al. Electronic health records documentation in nursing: nurses' perceptions, attitudes, and preferences
Ell et al. Patient navigation and case management following an abnormal mammogram: a randomized clinical trial
Hodnett et al. Alternative versus conventional institutional settings for birth
Nassar et al. Autism spectrum disorders in young children: effect of changes in diagnostic practices
Sellbom et al. On the hierarchical structure of mood and anxiety disorders: confirmatory evidence and elaboration of a model of temperament markers.
Bickell et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment
Prados-Torres et al. Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis
Miller et al. Report of a National Workshop on Screening for Cancer of the Cervix.
Leyden et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process
Cals et al. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial
Meletiche et al. Quality‐of‐life differences between patients with episodic and transformed migraine
Carter et al. The challenge of overdiagnosis begins with its definition
Efficace et al. Spiritual issues and quality of life assessment in cancer care
Kadam et al. Clinical multimorbidity and physical function in older adults: a record and health status linkage study in general practice
Chen et al. Genetic association study of BDNF in depression: Finding from two cohort studies and a meta‐analysis
Klein et al. Psychosocial stress at work and perceived quality of care among clinicians in surgery
Marras et al. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation
Morgado et al. Predictors of uncontrolled hypertension and antihypertensive medication nonadherence
Fisher et al. Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk
Bamford et al. Can primary care record review facilitate earlier diagnosis of dementia?
Kalenderian et al. The development of a dental diagnostic terminology
Langenbruch et al. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis
Dai et al. Birth defects surveillance in China
David et al. Diagnostic accuracy in patients admitted to hospitals with cellulitis
Hawkes et al. Feasibility of brief psychological distress screening by a community-based telephone helpline for cancer patients and carers

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
C12 Rejection of a patent application after its publication